D. E. Shaw & Co., Inc. - AXOVANT GENE THERAPIES LTD ownership

Back to all holdings Add to watchlist

AXOVANT GENE THERAPIES LTD's ticker is AXGT and the CUSIP is G0750W203. A total of 51 filers reported holding AXOVANT GENE THERAPIES LTD in Q3 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of AXOVANT GENE THERAPIES LTD
ValueSharesWeighting
Q2 2020$456,000
+97.4%
161,702
+70.5%
0.00%–
Q1 2020$231,000
+80.5%
94,843
+278.0%
0.00%–
Q4 2019$128,000–25,093–0.00%–
 Download
Other shareholders

There were no reported owners of AXOVANT GENE THERAPIES LTD in Q3 2020.

NameSharesValueWeighting ↓
View complete list of AXOVANT GENE THERAPIES LTD shareholders